Xp11 Translocation renal cell carcinoma in adults: Expanded clinical, pathologic, and genetic spectrum

American Journal of Surgical Pathology

Volumn 31, Issue 8, 2007, Pages 1149-1160

  Argani, Pedram ^a,b,j   Olgac, Semra ^c   Tickoo, Satish K ^c   Goldfischer, Michael ^d   Moch, Holger ^e   Chan, David Y ^a   Eble, John N ^f   Bonsib, Stephen M ^f   Jimeno, Mireya ^g   Lloreta, Josep ^h   Billis, Athanase ⁱ   Hicks, Jessica ^a   De Marzo, Angelo M ^a,b   Reuter, Victor E ^c   Ladanyi, Marc ^c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^f INDIANA UNIVERSITY   (United States)

^g UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^h UNIVERSITAT POMPEU FABRA   (Spain)

ⁱ UNIVERSITY OF CAMPINAS   (Brazil)

^j JOHNS HOPKINS HOSPITAL   (United States)

more..

Author keywords

Chromosome translocation; Renal cell carcinoma; TFE3

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURGERY; CHROMOSOME TRANSLOCATION; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE FUSION; GENE TRANSLOCATION; GIANT CELL TUMOR; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY PELVIS; LYMPH NODE; MALE; METASTASIS; MORPHOLOGICAL TRAIT; NEPHROLITHIASIS; SPINDLE CELL CARCINOMA; TUMOR CALCINOSIS; XANTHOGRANULOMATOUS PYELONEPHRITIS;

ADULT; AGED; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; CALCINOSIS; CARCINOMA, RENAL CELL; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, X; CYTOGENETIC ANALYSIS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; KIDNEY NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; TRANSLOCATION, GENETIC;

EID: 33847040976     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/PAS.0b013e318031ffff     Document Type: Article

References (24)

1. Allory Y, Ouazana D, Boucher E, et al. Papillary renal cell carcinoma. Prognostic value of morphologic subtypes in a clinicopathologic study of 43 cases. Virchows Arch. 2003;442:336-342.
2. Argani P, Beckwith JB. Renal neoplasms of childhood. In: Mills SE, ed. Sternberg's Diagnostic Surgical Pathology. Vol 2. Philadelphia: Lippincott, Williams & Wilkins; 2004:2000-2033.
3. Argani P, Ladanyi M. Renal carcinomas associated with Xp11.2 translocations/TFE3 gene fusions. In: Eble JN, Sauter G, Epstein J, et al, eds. Pathology and Genetics of Tumors of the Urinary System & Male Genital Organs. Lyon, France: IARC; 2004:37-38.
4. Argani P, Ladanyi M. Translocation carcinomas of the kidney. Clinics Lab Med. 2005;25:363-378.
5. Argani P, Faria PA, Epstein JI, et al. Primary renal synovial sarcoma. Morphologic and molecular delineation of an entity previously included among embryonal sarcomas of the kidney. Am J Surg Pathol. 2000;24:1087-1096.
6. Argani P, Antonescu CR, Illei PB, et al. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma. A distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol. 2001;159:179-192.
7. Argani P, Hawkins A, Griffin CA, et al. A distinctive pediatric renal neoplasm characterized by epithelioid morphology, basement membrane production, focal HMB45 immunoreactivity, and t(6; 11) (p21.1; q12) chromosome translocation. Am J Pathol. 2001;158:2089-2096.
8. Argani P, Antonescu CR, Couturier J, et al. PRCC-TFE3 renal carcinomas. Morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X;1) (p11.2;q21). Am J Surg Pathol. 2002;26:1553-1566.
9. Argani P, Lal P, Hutchinson B, et al. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay. Am J Surg Pathol. 2003;27:750-761.
10. Argani P, Lui MY, Couturier J, et al. Cloning of a novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23). Oncogene. 2003;22:5374-5378.
11. Argani P, Laé M, Hutchinson B, et al. Renal carcinomas with the t(6;11)(p21;q12). Clinicopathologic features and demonstration of the specific Alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA-PCR. Am J Surg Pathol. 2005;29:230-240.
12. Argani P, Tsuda M, Chen M-S, et al. Overexpression of the MET tyrosine kinase receptor in tumors with TFE3 gene fusions. Mod Pathol. 2006;19(S1):297A (abstract no. 1381).
13. Bruder E, Passera O, Harms D, et al. Morphologic and molecular characterization of renal cell carcinoma in children and young adults. Am J Surg Pathol. 2004;28:1117-1132.
14. Clark J, Lu Y-J, Sidhar SK, Parker C, et al. Fusion of splicing factor genes PSF and NonO (p54nrb) to the TFE3 gene in papillary renal cell carcinoma. Oncogene. 1997;15:2233-2239.
15. Dal Cin P, Stas M, Sciot R, et al. Translocation (X;1) reveals metastasis 31 years after renal cell carcinoma. Cancer Genet Cytogenet. 1998;101:58-61.
16. Green FL, Page DL, Fleming ID, et al, eds. American Joint Committee on Cancer Staging Manual. 6th ed. New York: Springer-Verlag; 2003.
17. Jemal A, Siegel R, Ward E, et al. Cancer Statistics 2006. CA Cancer J Clin. 2006;56:106-130.
18. Láe M, Argani P, Olshen AB, et al. Global gene expression profiles of renal carcinomas with Xp11 translocations (TFE3 gene fusions) suggest a closer relationship to alveolar soft part sarcoma than to adult type renal cell carcinomas. Mod Pathol. 2004;17(S1):163A (abstract no. 682).
19. Láe M, Saito T, Barr FG, et al. Expression profiling of pediatric sarcomas with chimeric transcription factors: a study of 153 samples. Mod Pathol. 2004;17(S1):330A (abstract no. 1390).
20. Meyer PN, Clark JL, Flanigan RC, et al. Xp11.2 translocation renal cell carcinoma with very aggressive course in five adult patients. Mod Pathol. 2006;19(S1):50A.
21. Parwani AV, Husain AN, Epstein JI, et al. Low-grade myxoid renal epithelial neoplasms with distal nephron differentiation. Hum Pathol 2001;32:506-512.
22. Salles PG, Soto M. Kidney carcinoma associated with Xp11.2 translocation/TFE3 (ASPL-TFE3) gene fusion. Int Braz Jour Urol. 2005;31:251-254.
23. Srigley J. Mucinous tubular and spindle cell carcinoma. In: Eble JN, Sauter G, Epstein J, et al, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumors of the Urinary System & Male Genital Organs. Lyon, France: IARC; 2003:40.
24. Tsuda M, Davis IJ, Argani P, et al. TFE3 fusions activate MET signalling by transcriptional upregulation, defining another class of tumors as candidates for therapeutic MET inhibition. Cancer Res. 2007;67:919-929.